₹ 0.6 Cr
Volume Transacted
(Nov 7, 2024)
2.1 K
Stocks Traded
(Nov 7, 2024)
Last Updated on: Nov 08, 2024
Glaxosmithkline Pharmaceuticals Ltd
NSE: GLAXO
YEARLOW
₹ 1423
Last updated on: Nov 07, 2024
Open Demat Account
Enter your mobile no. to continue
+91
*By signing up you agree to our terms & conditions
50 Years
of Trust & Legacy
₹0 AMC
for First Year
₹0 Brokerage
on Delivery, Intraday, Currency and NSE F&O
No data available
* All values are consolidated
Last Updated time:
The current market price or CMP refers to the price at which the securities are trading in the share market. Current price in Over-the-counter costs: The following current price depends upon the bid price & the asking price when a financial asset is sold over-the-counter(OTC). Current Price in Bond Market: The current price of a bond is determined by measuring the actual interest rate against the bid-related interest rate. The par or the face value is then calculated to represent the remaining interest payments due which occur before the maturity of the bond.
1M
1Y
3Y
5Y
Date | Price (₹) | Day Open (₹) | Day High (₹) | Day Low (₹) |
---|
07 Nov 2024 | 2610.25 | 2639.95 | 2643.75 | 2586.3 |
06 Nov 2024 | 2632.2 | 2595.9 | 2649.95 | 2593.85 |
05 Nov 2024 | 2595.9 | 2670 | 2670 | 2592.75 |
04 Nov 2024 | 2612.7 | 2729.7 | 2729.7 | 2602 |
01 Nov 2024 | 2729.7 | 2719.85 | 2746.15 | 2719.85 |
31 Oct 2024 | 2719.8 | 2701.3 | 2760 | 2678.05 |
30 Oct 2024 | 2677.25 | 2719.9 | 2739.8 | 2601 |
29 Oct 2024 | 2629.75 | 2648.95 | 2674.05 | 2620.9 |
28 Oct 2024 | 2642.35 | 2595.95 | 2668.7 | 2542.55 |
25 Oct 2024 | 2586.7 | 2668.25 | 2700 | 2505 |
Date | Price (₹) |
---|---|
07 Nov 2024 | 2610.25 |
06 Nov 2024 | 2632.2 |
05 Nov 2024 | 2595.9 |
04 Nov 2024 | 2612.7 |
01 Nov 2024 | 2729.7 |
31 Oct 2024 | 2719.8 |
30 Oct 2024 | 2677.25 |
29 Oct 2024 | 2629.75 |
28 Oct 2024 | 2642.35 |
25 Oct 2024 | 2586.7 |
Market Value
₹ 0
Asset Value
₹ 0
* All values are in Rupees
Historical Revenue of Glaxosmithkline Pharmaceuticals Ltd
Revenue term means the amount of money a company earns from its primary business activities such as the sales of its products & services.\r\r\n\r\r\nTypes of Revenue:\r\r\n\r\r\n1. Operating revenue: It refers to the income generated from the core business activities, which are sales of goods or services rendered.\r\r\n\r\r\n2. Non-Operating revenue: It is the income generated from secondary sources unrelated to the primary business. Examples include rents, dividends, interest, and royalty fees.\r\r\n\r\r\nFormula for Revenue:\r\r\n\r\r\nThe formula for calculating revenue is based on two goods & services:\r\r\n\r\r\nFor goods:\r\r\nRevenue = Avg unit price x Number of Units sold\r\r\n\r\r\nFor services:\r\r\nRevenue = Avg unit price x Number of Customers served.
No data available
* All values are in ₹ crore
Historical Net Profit of Glaxosmithkline Pharmaceuticals Ltd
Net profit is the amount of money a company retains after accounting for all expenses, depreciation, interest, taxes, and other deductions.\r\r\n\r\r\nNet Profit formula is expressed as:\r\r\n\r\r\nNet Profit = Total Revenue - Total Expense\r\r\n\r\r\nNet Profit Margin Ratio:\r\r\n\r\r\nNet Profit Margin Ratio = Net Profit / Total Revenue
No data available
* All values are in ₹ crore
GSK Pharma gains as Q2 PAT rises 15% YoY to Rs 249 cr
Profit before exceptional item and tax was at Rs 338.70 crore in the September 2024 quarte...
30 Oct 202410:39
Board of GlaxoSmithKline Pharmaceuticals recommends Special Interim Dividend
GlaxoSmithKline Pharmaceuticals announced that the Board of Directors of the Company at it...
29 Oct 202416:10
GlaxoSmithKline Pharmaceuticals to declare Quarterly Result
GlaxoSmithKline Pharmaceuticals will hold a meeting of the Board of Directors of the Compa...
25 Oct 202410:38
GSK Pharma Q1 PAT climbs 39% YoY to Rs 182 crore
Revenue from operations grew by 9.89% year on year (YoY) to Rs 811 crore during the quarte...
03 Aug 202412:25
GlaxoSmithKline Pharmaceuticals to convene board meeting
GlaxoSmithKline Pharmaceuticals will hold a meeting of the Board of Directors of the Compa...
18 Jul 202410:38
Glaxosmithkline Pharmaceuticals announces change in senior management
Glaxosmithkline Pharmaceuticals announced that Dr. Shalini Menon has been appointed as Exe...
05 Jul 202413:26
FAQs for 52 Week Low of Glaxosmithkline Pharmaceuticals Ltd
Why is it important to track the 52-week low of Glaxosmithkline Pharmaceuticals Ltd stocks?
What factors can lead to Glaxosmithkline Pharmaceuticals Ltd stocks hitting a 52-week low?
Should investors buy Glaxosmithkline Pharmaceuticals Ltd stocks when they hit a 52-week low?
How often should investors monitor the 52-week low of Glaxosmithkline Pharmaceuticals Ltd stocks?
How can an investor assess the risk of buying Glaxosmithkline Pharmaceuticals Ltd stock at their 52-week low?
Should investors consider the overall market trend when evaluating Glaxosmithkline Pharmaceuticals Ltd stocks at their 52-week low?
Unlimited trading at just
Rs. 199*